LOUISVILLE, Ky.–(BUSINESS WIRE)–Humana Inc. (the “company”) (NYSE: HUM) announced today that it has priced a public offering of $1.25 billion in aggregate principal amount of senior notes. These senior notes are comprised of $500 million of the company’s 5.75 percent senior notes, due 2028 (the “2028 notes”), at 99.705 percent of the principal amount and … [Read more…]
SnapLogic’s no/low code, scalable intelligent integration platform saves Abano Healthcare a quarter of a million dollars with its simplicity and effectiveness SYDNEY, Australia–(BUSINESS WIRE)–Abano Healthcare, Australasia’s largest dental support organisation (DSO), leverages SnapLogic, a leader in intelligent integration and enterprise automation, to power its modernisation journey. With SnapLogic’s scalable, no-code platform, Abano Healthcare, which serves … [Read more…]
BEIJING–(BUSINESS WIRE)–InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that 10 studies on the BTK inhibitor orelabrutinib developed by InnoCare were selected at the 64th American Society of Hematology (ASH) Annual Meeting on December 10-13, 2022, which will be held online and … [Read more…]
2023 Grant Application Process Now Open for Up to $300,000 in Funding TEMPE, Ariz–(BUSINESS WIRE)–Align Technology, Inc. (NASDAQ: ALGN) today announced the opening of its 2023 Research Award Program to support clinical and scientific dental research in universities across the globe. This year, up to $300,000 will be awarded to university faculty for scientific and … [Read more…]
TORONTO & DALLAS–(BUSINESS WIRE)–$PINK.V #AI–Perimeter Medical Imaging AI, Inc. (TSX-V: PINK) (OTC: PYNKF) (FSE: 4PC) (“Perimeter” or the “Company”) – a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address high unmet medical needs, announced the results of its 2022 annual and special meeting of shareholders (the “Meeting”) … [Read more…]
SAN DIEGO–(BUSINESS WIRE)–Arcturus Therapeutics Holdings Inc. (the “Company,” “Arcturus,” Nasdaq: ARCT), a global, late-stage clinical messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today announced that the Company will present at the following investor conferences. Guggenheim 4th Annual Immunology and Neurology Day … [Read more…]
Q3 Revenue of $104.3 Million Up 22% Year-Over-Year; Company Raises Full-Year 2022 Revenue and Adjusted EBITDA Guidance Co-founder and CEO Stan Vashovsky announces his retirement effective December 31st; DocGo President Anthony Capone named new CEO; Mr. Vashovsky will consult with the Company through 2023 to assist with the transition Company to host investor conference call … [Read more…]
Net sales in the first quarter of fiscal 2023 totaled $405.9 million, an all-time quarterly high and up 39% year-over-year; foreign currency had a 5% unfavorable impact on net sales compared to the first quarter of fiscal 2022 Operating income of $13.6 million, or 3.3% of net sales, compared to operating income of $4.8 million, … [Read more…]
Findings from the first clinical trial program comparing the use of Teva’s Digihaler® System to standard of care in asthma management will be presented across six abstracts TEL AVIV, Israel & PARSIPPANY, N.J.–(BUSINESS WIRE)–Teva Pharmaceuticals USA, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced that new findings from … [Read more…]
BILLERICA, Mass.–(BUSINESS WIRE)–$BRKR #BRKR—Bruker Corporation (Nasdaq: BRKR) announced today it will participate in the 2022 Jefferies London Healthcare Conference. Gerald Herman, Executive Vice President & Chief Financial Officer will present and participate in an analyst moderated question and answer session on behalf of the Company on Tuesday, November 15, 2022 at 12:00 PM Eastern Time. … [Read more…]
